CliffBio
small molecule

MULTIPLE VITAMINS INJECTION PEDIATRIC

ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K

Loss of exclusivityDecember 2026FDA regulatory exclusivity expiry
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameMULTIPLE VITAMINS INJECTION PEDIATRIC
Active ingredientASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K
Strength80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL
Dosage formINJECTABLE
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalApril 2026
Marketing statusRX

Regulatory exclusivity

CodeExpires
CGTDecember 2026

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.

MULTIPLE VITAMINS INJECTION PEDIATRIC patent cliff — loss of exclusivity December 2026 | CliffBio